Position in NVO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,035,053
+$361,091 QoQ
Shares Held
42,450
-6.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#375
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rodgers Brothers Inc. holds $137,046,562 across 11 Drug Manufacturers - General names. NVO ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,538 | $66,613,948 | |
| 2 | ABBV |
AbbVie Inc.
|
127,464 | $32,075,040 | |
| 3 | JNJ |
Johnson & Johnson
|
63,682 | $16,173,317 | |
| 4 | MRK |
Merck & Co., Inc.
|
102,689 | $13,195,536 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,062 | $4,555,552 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
42,450 | $2,035,053 | |
| 7 | PFE |
Pfizer Inc
|
33,453 | $805,548 | |
| 8 | AMGN |
Amgen Inc
|
1,897 | $686,941 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,035,053 | 42,450 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,673,962 | 45,550 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,409,168 | 47,350 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||